Annual Current Liabilities
$1.62 M
+$701.00 K+75.98%
December 1, 2023
Summary
- As of February 7, 2025, DRMA annual total current liabilities is $1.62 million, with the most recent change of +$701.00 thousand (+75.98%) on December 1, 2023.
- During the last 3 years, DRMA annual current liabilities has fallen by -$2.16 million (-57.09%).
- DRMA annual current liabilities is now -57.09% below its all-time high of $3.78 million, reached on December 31, 2020.
Performance
DRMA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$1.95 M
+$27.70 K+1.44%
September 1, 2024
Summary
- As of February 7, 2025, DRMA quarterly total current liabilities is $1.95 million, with the most recent change of +$27.70 thousand (+1.44%) on September 1, 2024.
- Over the past year, DRMA quarterly current liabilities has increased by +$322.50 thousand (+19.86%).
- DRMA quarterly current liabilities is now -48.56% below its all-time high of $3.78 million, reached on December 31, 2020.
Performance
DRMA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
DRMA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +76.0% | +19.9% |
| 3 y3 years | -57.1% | +185.0% |
| 5 y5 years | -5.8% | +185.0% |
DRMA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +76.0% | at high | +185.0% |
| 5 y | 5-year | -57.1% | +76.0% | -48.6% | +185.0% |
| alltime | all time | -57.1% | +76.0% | -48.6% | +185.0% |
Dermata Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.95 M(+1.4%) |
| Jun 2024 | - | $1.92 M(+39.8%) |
| Mar 2024 | - | $1.37 M(-15.5%) |
| Dec 2023 | $1.62 M(+76.0%) | $1.62 M(+77.1%) |
| Sep 2023 | - | $916.80 K(+34.3%) |
| Jun 2023 | - | $682.90 K(-43.4%) |
| Mar 2023 | - | $1.21 M(+30.8%) |
| Dec 2022 | $922.60 K | $922.60 K(-38.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.50 M(+10.1%) |
| Jun 2022 | - | $1.37 M(+14.7%) |
| Mar 2022 | - | $1.19 M(-21.4%) |
| Dec 2021 | $1.52 M(-59.9%) | $1.52 M(+26.9%) |
| Sep 2021 | - | $1.20 M(-27.2%) |
| Jun 2021 | - | $1.64 M(+74.9%) |
| Mar 2021 | - | $939.20 K(-75.2%) |
| Dec 2020 | $3.78 M(+119.6%) | $3.78 M |
| Dec 2019 | $1.72 M | - |
FAQ
- What is Dermata Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Dermata Therapeutics?
- What is Dermata Therapeutics annual current liabilities year-on-year change?
- What is Dermata Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Dermata Therapeutics?
- What is Dermata Therapeutics quarterly current liabilities year-on-year change?
What is Dermata Therapeutics annual total current liabilities?
The current annual current liabilities of DRMA is $1.62 M
What is the all time high annual current liabilities for Dermata Therapeutics?
Dermata Therapeutics all-time high annual total current liabilities is $3.78 M
What is Dermata Therapeutics annual current liabilities year-on-year change?
Over the past year, DRMA annual total current liabilities has changed by +$701.00 K (+75.98%)
What is Dermata Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of DRMA is $1.95 M
What is the all time high quarterly current liabilities for Dermata Therapeutics?
Dermata Therapeutics all-time high quarterly total current liabilities is $3.78 M
What is Dermata Therapeutics quarterly current liabilities year-on-year change?
Over the past year, DRMA quarterly total current liabilities has changed by +$322.50 K (+19.86%)